Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$15.5 - $22.48 $1.46 Million - $2.12 Million
-94,100 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$9.4 - $16.7 $100,918 - $179,291
-10,736 Reduced 10.24%
94,100 $1.42 Million
Q3 2020

Nov 05, 2020

BUY
$10.54 - $24.96 $16,484 - $39,037
1,564 Added 1.51%
104,836 $1.1 Million
Q2 2020

Aug 12, 2020

BUY
$21.87 - $33.11 $754,055 - $1.14 Million
34,479 Added 50.12%
103,272 $2.52 Million
Q1 2020

May 12, 2020

BUY
$16.25 - $35.28 $196,625 - $426,888
12,100 Added 21.34%
68,793 $1.66 Million
Q4 2019

Jan 27, 2020

BUY
$14.17 - $20.3 $648,986 - $929,740
45,800 Added 420.45%
56,693 $977,000
Q3 2019

Oct 31, 2019

BUY
$14.42 - $22.2 $157,077 - $241,824
10,893 New
10,893 $157,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.